Expanded Access to Investigational Therapies (R01)

The goal of this grant is to develop a framework to guide the improvement of the U. S. system for expanded access to investigational therapies, taking into consideration ethical, scientific, regulatory, financial, and infrastructural issues.

Research to improve our understanding of the barriers

to expanded access, such as regional and economic bias, will benefit the U. S. public at large by providing researchers and policymakers across the United States a better understanding of the issues implicating expanding access to investigational therapies.

• Research and examine the landscape and develop a framework to guide the improvement of the U. S. system for expanded access to investigational therapies, taking into consideration ethical, scientific, regulatory, financial, and infrastructural issues.

Articulate guiding principles and an ethical framework for expanded access to investigational therapies.

• Research and address scientific considerations and implications for medical product clinical development programs when the investigational product is available through an expanded access program.

• Research and address regulatory considerations and the role of FDA, including providing guidance for the collection and evaluation of both safety and efficacy data relating to investigational products provided through expanded access programs.

• Research and address business and financial considerations relating to offering investigational products through expanded access programs, including consideration of:
o Financial considerations for both small and large companies, and business models for manufacturing and furnishing the products outside of the context of a development program; o Liability and related legal considerations relating to providing unapproved therapies to patients outside of the context of a research protocol; and o Implications for continued access after approval if the product is not affordable to a patient who had been granted expanded access.

o Identify characteristics of the optimal structure and governance of a system for expanded access, including making recommendations relating to:
o Guidance to and structure of ethics review committees; o Systems for reporting and accountability of companies providing investigational products through an expanded access mechanism; and o Improvement of information sharing among the multiple decision making parties (provider, sponsor, and FDA) to facilitate patient access to investigational therapies through the most appropriate means (e.g., clinical trials, expanded access programs, individual access requests).

Related Programs

Food and Drug Administration_Research

Department of Health and Human Services


Agency: Department of Health and Human Services

Office: Food and Drug Administration

Estimated Funding: $300,000


Who's Eligible


Relevant Nonprofit Program Categories





Obtain Full Opportunity Text:
Not Available

Additional Information of Eligibility:
The following organization is eligible to apply: National Academy of Sciences, Engineering, and Medicine (the Academies)

Full Opportunity Web Address:


Contact:
Shashi MalhotraGrants Management SpecialistPhone 240-402-7592

Agency Email Description:
Shashi.Malhotra@fda.hhs.gov

Agency Email:
Shashi.Malhotra@fda.hhs.gov

Date Posted:
2016-10-24

Application Due Date:
2017-01-13

Archive Date:
2017-02-12



Social Entrepreneurship
Spotlight



GiveEasy – A Thriving Social Enterprise


GiveEasy is a social enterprise startup geared for growth after partnering with Australia Post, a move that will set them up in the Australian forefront.




Nonprofit Jobs in South Carolina

  Program Director Jobs
  Executive Director Jobs
  Social Services Jobs
  Executive Director Jobs
  Substance Abuse Jobs





More Federal Domestic Assistance Programs


Juvenile Justice Education Collaboration Assistance | Post-9/11 Veterans Educational Assistance | Cooperative Agreements for State Treatment Outcomes and Performance Pilot Studies Enhancement | Emergency System for Advance Registration of Health Professional Volunteers | Water 2025 |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders